Gilead loses key patent claims for Sovaldi in China, opening door to earlier generic entry Gilead loses key patent claims for Sovaldi in China, opening door to earlier generic entry – I-MAK

Gilead loses key patent claims for Sovaldi in China, opening door to earlier generic entry

Media Article 17 Aug 2018

Partner with us now to build
a more just and equitable
medicine system for all.